Clinical Trials Logo

Syphilis Female clinical trials

View clinical trials related to Syphilis Female.

Filter by:
  • None
  • Page 1

NCT ID: NCT03752112 Recruiting - Syphilis Female Clinical Trials

Trial Evaluating the Clinical Efficacy of Cefixime for Treatment of Early Syphilis in Non-pregnant Women

Start date: November 22, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Hypotheses The antibiotic, Cefixime, for use in non-pregnant women with early syphilis will be efficacious and safe. Primary Objective The primary objective of the study is to demonstrate the efficacy, as measured by a 4 fold decrease in Rapid Plasma Reagin (RPR) titer from baseline to 6 months after treatment, with Cefixime 400mg taken orally two times a day for 10 consecutive days. Secondary Objective The secondary objective of the study is to determine the safety, as measured by the number of grade 3 or greater toxicities experienced, using the NIH/NCI toxicity score, during or after treatment with Cefixime 400mg taken orally two times a day for 10 consecutive days.